GoodRx Holdings, Inc. (GDRX) Reports In-Line Q1 EPS ; Offers Guidance

GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q1 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $194.01 million versus the consensus estimate of $185.28 million.

2026 Outlook:-

Revenue between $765 - $785 million vs consensus $764.8 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.

You May Also Be Interested In

• Smith & Wesson Brands (SWBI) Tops Q1 EPS by 13c
• Oxford Industries (OXM) Tops Q2 EPS by 4c; offers guidance
• After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM